Pain Management Medical Journal Features BioElectronics' Innovative Pain Products Because Pain is Not a Druggable Disease
FREDERICK, Md., Jan. 9, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the publication of feature article The Case for Over-the-Counter Shortwave Therapy: Safe and Effective Devices for Pain Management in the peer reviewed journal Pain Management (http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60). The current methods of drug-based analgesia are often ineffective, at best only temporarily masking pain while not treating or providing the benefit of enhanced recovery.
(Photo: http://photos.prnewswire.com/prnh/20140109/PH43397)
The paper makes the case for more widespread use of radio frequency shortwave devices to overcome the dosage limitations, costs, and side-effects of pharmacological-based pain relief. To view the complete article, please visit http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60
There is a dire unmet medical need for effective and safe pain therapy. For decades, physicians have used pulsed shortwave therapy in hospitals and clinics to reduce pain and inflammation and accelerate healing. BioElectronics has taken the therapy mode, miniaturized the device, lowered the power level and honed the signal to provide low cost superior 24-hour extended duration relief. The devices provides 5x better pain relief than OTC drugs, are 100% safer, and provide 720-hours of flexible on/off therapy for under $30.00 retail, or $.04 per hour.
Clinical Research
In addition to its six (6) published studies, there is on-going basic research at the Clinical Science and Engineering Research Center – State University of New York, Binghamton, NY and other leading medical institutions that are conducing additional clinical research studies:
| Tufts Dental School, Boston, Massachusetts |
3rd. Molar Extraction, Pain and Edema |
| Tufts Dental School |
Myofascial Pain |
| Tufts Medical School |
Chronic Wounds |
| University of British Colombia, Vancouver, Canada |
Plantar Fasciitis recovery at 26 weeks |
| University of Otago, New Zealand |
Lower Back Pain |
| University Hospital Ghent, Belgium |
Bilateral Hernia Surgical Recovery |
| University Hospital G. Martin, Messina, Italy |
Osteoarthritis |
| Aarhus University Hospital, Aalborg, Denmark |
Venous Ulcer Wound Healing |
The details on previously completed and published clinical trials can be found at http://www.bielcorp.com/clinical-evidence/.
About BioElectronics Corporation
BioElectronics is the leader in consumer medical devices that reduce pain, inflammation and accelerate healing. Its products are ActiPatch® Musculoskeletal Pain Therapy for back, knee, and other musculoskeletal complaints; RecoveryRx® for chronic and post-operative wound care; HealFast® Veterinary Therapy, Allay® Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy. Visit www.bielcorp.com for more information.
About the Pain Management Journal
Future Medicine Ltd, the publisher, has developed an innovative publishing portfolio to reflect the advances in postgenomic medicine and to guide best clinical practice in modern medicine. The Future Medicine journal collection provides healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in the light of advances in molecular medicine and clinical practice.
BioElectronics Contact:
Paul Knopick
940.262.3584
[email protected]
SOURCE BioElectronics Corporation
Share this article